Melbourne-based healthcare AI leader Heidi has announced a significant expansion of its platform, marking its evolution from a specialized AI scribe into a comprehensive AI Care Partner. The company has launched Heidi Evidence, a clinical research tool, and Heidi Comms, a patient communication coordinator, alongside the strategic acquisition of UK-based AI pioneer AutoMedica. These developments aim to redefine healthcare delivery by integrating real-time clinical reasoning with administrative automation, addressing critical needs for clinicians globally.
Bridging the Clinical Knowledge Gap
With medical knowledge doubling every 73 days, clinicians face an impossible challenge in staying current with the latest research and methods. Heidi Evidence addresses this by providing a clinical-grade research tool directly within its platform, offering a transparent alternative to general-purpose AI. This tool is designed to restore clinical authority and patient comfort by moving away from search engine-style research during consultations.
Heidi Evidence ensures the integrity of its information through partnerships with authoritative sources like NICE, BMJ Group, and HealthPathways, reflecting regional standards. The platform is committed to being permanently ad-free, ensuring clinical decisions are based on pure evidence rather than commercial influence. Its traceable intelligence provides concise summaries with transparent citations, allowing clinicians to verify every insight and maintain trust.
Strategic Acquisition and Regulatory Alignment
The acquisition of AutoMedica significantly accelerates Heidi's technical and regulatory capabilities, particularly within the United Kingdom. AutoMedica's evidence-led AI framework and strong relationships with national regulators will underpin the new Heidi Evidence tool. This move also grants Heidi access to the prestigious MHRA AI Airlock, a regulatory sandbox for pioneering healthcare AI technologies.
This strategic purchase reinforces Heidi's commitment to being a regulator-aligned partner for global health systems and extends its footprint in the UK market. Dr. Thomas Kelly, Co-Founder and CEO of Heidi, emphasized that for AI to be a true care partner, the integrity of its evidence must be non-negotiable. The acquisition ensures that the information provided is free from the ambiguity of commercial influence.
A Foundation of Trust and Technology
Heidi Evidence is built in part on Anthropic’s Claude AI models, chosen for their strength in interpreting complex clinical conversations and synthesizing dense medical literature. This technology is particularly suited for high-stakes healthcare environments where precision and reliability are paramount for patient safety. The choice reflects an evidence-based, safety-first approach that aligns with Heidi’s core market position and philosophy.
This focus on clinical integrity distinguishes Heidi from consumer AI models that often prioritize growth and monetization through advertising. By making Heidi Evidence free for individual clinicians, the company uses its enterprise revenue to subsidize access for practitioners in resource-constrained markets. This ethical approach provides a professional, bias-free alternative to ad-supported search engines that can compromise clinical accuracy.
Expanding the AI Care Partner Vision
Alongside its clinical tool, the company launched Heidi Comms, an AI partner designed to help healthcare teams coordinate patient communications. This system automates and manages calls, bookings, reminders, and follow-ups, freeing up valuable administrative time. The introduction of this tool further solidifies Heidi's transition into a holistic platform supporting both clinical and operational workflows.
Together, these announcements showcase a clear strategy to build a defensible, globally relevant platform that healthcare systems are demanding. Having already supported over 100 million clinical interactions, Heidi is scaling its capabilities without compromising trust. This expansion demonstrates a deep understanding of the need to automate administrative work so clinicians can focus on what matters most: their patients.
Heidi's latest initiatives represent a pivotal moment in the application of AI in healthcare, setting a new standard for trust, transparency, and clinical utility. By integrating an ad-free evidence engine and expanding its administrative automation tools, the company is building a comprehensive ecosystem designed to enhance clinical capacity. With strong investor backing and a growing global presence, Heidi is positioning itself as an indispensable partner in shaping a more efficient and evidence-based future for healthcare.